Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Bravecto Plus"'
Autor:
Nadja Rohdich, Eva Zschiesche, Oliver Wolf, Wolfgang Loehlein, Zvezdelina Kirkova, Petar Iliev, Dhimitër Rapti, Rezart Postoli, Balázs Capári, Róbert Farkas, Rainer K. A. Roepke
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-7 (2018)
Abstract Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) was developed for the treatment of nematode infections as well as providing 12 weeks of protection against insect and acarine par
Externí odkaz:
https://doaj.org/article/b9fd5fa0c4ab416a9b3174dd8023a7b5
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-4 (2018)
Abstract Background The efficacy of the fixed combination of fluralaner plus moxidectin for the treatment of Otodectes cynotis infestations was evaluated in cats after topical application. Methods Sixteen cats experimentally infested with O. cynotis
Externí odkaz:
https://doaj.org/article/08ff3fdc6ae44489934dc34cd2a6301c
Autor:
Nadja Rohdich, Eva Zschiesche, Oliver Wolf, Wolfgang Loehlein, Thierry Pobel, Maria José Gil, Rainer K. A. Roepke
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-11 (2018)
Abstract Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against t
Externí odkaz:
https://doaj.org/article/5b46b025648b460db7cf10e22b246ccc
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-3 (2018)
Abstract Background Fluralaner provides efficacy against feline ectoparasites following topical administration. Moxidectin is routinely used to treat gastrointestinal nematode infections and prevent heartworm disease caused by Dirofilaria immitis. Pr
Externí odkaz:
https://doaj.org/article/f99655c59a38491b9c42343ca4d3d4d9
Autor:
Róbert Farkas, Zvezdelina Kirkova, Wolfgang Loehlein, Nadja Rohdich, Petar Iliev, Dhimitër Rapti, Balázs Capári, Rainer K. A. Roepke, Rezart Postoli, Oliver Wolf, Eva Zschiesche
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-7 (2018)
Parasites & Vectors
Parasites & Vectors
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) was developed for the treatment of nematode infections as well as providing 12 weeks of protection against insect and acarine parasites in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc50bfeabdefb40a1a199d99a5e10ba6
http://link.springer.com/article/10.1186/s13071-018-3169-x
http://link.springer.com/article/10.1186/s13071-018-3169-x
Publikováno v:
Parasites & Vectors
Parasites & Vectors, Vol 11, Iss 1, Pp 1-3 (2018)
Parasites & Vectors, Vol 11, Iss 1, Pp 1-3 (2018)
Background Fluralaner provides efficacy against feline ectoparasites following topical administration. Moxidectin is routinely used to treat gastrointestinal nematode infections and prevent heartworm disease caused by Dirofilaria immitis. Praziquante
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3a2f195de9e6d918de70de96cad008
https://doi.org/10.1186/s13071-018-3170-4
https://doi.org/10.1186/s13071-018-3170-4
Publikováno v:
Parasites & Vectors
Parasites & Vectors, Vol 11, Iss 1, Pp 1-4 (2018)
Parasites & Vectors, Vol 11, Iss 1, Pp 1-4 (2018)
Background The efficacy of the fixed combination of fluralaner plus moxidectin for the treatment of Otodectes cynotis infestations was evaluated in cats after topical application. Methods Sixteen cats experimentally infested with O. cynotis were allo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2db9d4b6f7b85679fcbdf26672b8668
http://europepmc.org/articles/PMC6241040
http://europepmc.org/articles/PMC6241040
Autor:
Eva Zschiesche, Rainer K. A. Roepke, Thierry Pobel, Wolfgang Loehlein, Nadja Rohdich, Maria José Gil, Oliver Wolf
Publikováno v:
Parasites & Vectors
Parasites & Vectors, Vol 11, Iss 1, Pp 1-11 (2018)
Parasites & Vectors, Vol 11, Iss 1, Pp 1-11 (2018)
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15b6dc408b37fd900c4cc56518237a7
https://pubmed.ncbi.nlm.nih.gov/30454052
https://pubmed.ncbi.nlm.nih.gov/30454052
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.